The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
Open accessAbstract
OBJECTIVES: The purpose of this study was to estimate the prevalence and correlates of four blood-borne viral infections among illicit drug injectors with up to 6 years of injecting experience. METHODS: We analyzed data from 716 volunteers recruited in 1988 and 1989. Test results for hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus, type 1 (HIV), and human T-lymphotropic virus types I and II (HTLV) were examined across six sequential cohorts defined by duration of drug injection. RESULTS: Overall, seroprevalence of HCV, HBV, HIV, and HTLV was 76.9%, 65.7%, 20.5% and 1.8%, respectively, and 64.7%, 49.8%, 13.9%, and 0.5%, respectively, among those who had injected for 1 year or less. Among the newest initiates, HCV and HBV were associated with injecting variables, and HIV was associated with sexual variables. CONCLUSIONS: The high rates of HCV, HBV, and HIV infections among short-term injectors emphasizes the need to target both parenteral and sexual risk reduction interventions early. Renewed efforts at primary prevention of substance abuse are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco
Chaisson, R. E. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420040099027 · Cited by 587
Robert-Guroff, M. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370220095034 · Cited by 347
Sex Differences in Addict Careers. 1. Initiation of Use
Hser, Y.-L., Anglin, M. D., & McGlothlin, W. (1987) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998709001499 · Cited by 215
R. van den Hoek, J. A., Coutinho, R. A., van Haastrecht, H. J. A., van Zadelhoff, A. W., & Goudsmit, J. (1988) · AIDS · doi:10.1097/00002030-198802000-00010 · Cited by 197
Vlahov, D., Anthony, J. C., Muñoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., & Polk, B. F. (1991) · Journal of Drug Issues · doi:10.1177/002204269102100406 · Cited by 194
Self-citationPrevalence, Incidence, and Risk Factors of Hepatitis C Virus Infection among Drug Users in Amsterdam
van den Hoek, J. A. R., van Haastrecht, H. J. A., Goudsmit, J., de Wolf, F., & Coutinho, R. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.4.823 · Cited by 182
Manns, A., & Blattner, W. A. (1991) · Transfusion · doi:10.1046/j.1537-2995.1991.31191096189.x · Cited by 174
The detection, transmission, and outcome of hepatitis C virus infection.
Mj, A. (1993) · PubMed · Cited by 163
van Ameijden, E. J. C., Van Den Hoek, J. A. R., Mientjes, G. H. C., & Coutinho, R. A. (1993) · European Journal of Epidemiology · doi:10.1007/bf00146260 · Cited by 161
Hepatitis C virus in intravenous drug users
Bell, J. R., Batey, R. G., Farrell, G. C., et al. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb136900.x · Cited by 142
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,148
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Self-citationBica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
Effect of Sleep Deprivation on Response to Immunizaton
Spiegel, K. (2002) · JAMA · doi:10.1001/jama.288.12.1469 · Cited by 633
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
Viral Infections During Pregnancy
Silasi, M., Cardenas, I., Kwon, J., Racicot, K., Aldo, P., & Mor, G. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12355 · Cited by 500
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Thorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
Protection against persistence of hepatitis C
Mehta, S. H., Cox, A., Hoover, D. R., Wang, X.-H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08435-0 · Cited by 440
Self-citationThe Epidemic Behavior of the Hepatitis C Virus
Pybus, O. G., Charleston, M. A., Gupta, S., Rambaut, A., Holmes, E. C., & Harvey, P. H. (2001) · Science · doi:10.1126/science.1058321 · Cited by 437
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02494.x · Cited by 396
Evans, J. L. (2003) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jtg137 · Cited by 314
Miller, C. L., Johnston, C., Spittal, P. M., Li, K., LaLiberté, N., Montaner, J. S. G., & Schechter, M. T. (2002) · Hepatology · doi:10.1053/jhep.2002.35065 · Cited by 259
Evolving Epidemiology of Hepatitis C Virus in the United States
Klevens, R. M., Hu, D. J., Jiles, R., & Holmberg, S. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis393 · Cited by 214
Effects of Race, Neighborhood, and Social Network on Age at Initiation of Injection Drug Use
Fuller, C. M., Borrell, L. N., Latkin, C. A., Galea, S., Ompad, D. C., Strathdee, S. A., & Vlahov, D. (2005) · American Journal of Public Health · doi:10.2105/ajph.2003.02178 · Cited by 184
Self-citationGarfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32823f9066 · Cited by 159
Self-citationSafer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives
Broadhead, R. S., Kerr, T. H., Grund, J.-P. C., & Altice, F. L. (2002) · Journal of Drug Issues · doi:10.1177/002204260203200113 · Cited by 153
Aberrant disgust responses and immune reactivity in cocaine-dependent men.
Ersche, K. D., Hagan, C. C., Smith, D. G., Abbott, S., Jones, P. S., Apergis-Schoute, A. M., & Döffinger, R. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.004 · Cited by 52
Hepatitis C and Individuals With Serious Mental Illnesses
Osher, F. C., Goldberg, R. W., Goodman, L. A., & Rosenberg, S. D. (2003) · Psychiatric Annals · doi:10.3928/0048-5713-20030601-09 · Cited by 10
Metadata
- Authors
- Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E.
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 1996-05
- Volume
- 86
- Issue
- 5
- Pages
- 655-661
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W2005937502
- Cited by
- 690
- References
- 14
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.